# Recursion

> AI-enabled drug discovery and digital biology platform.

## Why it is interesting

Industrialized phenomics at scale — Lux and CRV in rounds; a16z on investment list without named syndicate in press reviewed.

## Profile

- **Stage:** public
- **Status:** public
- **Industries:** biotech-life-sciences, ai-ml
- **Coverage:** full
- **Last updated:** 2026-07-24

## Key facts

- Series A (2016): $13M led by Lux (Lux Capital)
- Series B (2017): $60M led by DCVC; Lux, Menlo, CRV, Two Sigma among participants (TechCrunch)
- IPO (2021): NASDAQ: RXRX

## Investors in our directory

- https://venturecapitaltracker.com/fund/andreessen-horowitz
- https://venturecapitaltracker.com/fund/lux-capital
- https://venturecapitaltracker.com/fund/crv
- https://venturecapitaltracker.com/fund/menlo-ventures
- https://venturecapitaltracker.com/fund/two-sigma-ventures

---
Source: https://venturecapitaltracker.com/startup/recursion